Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-30

FDA Approved: DALFAMPRIDINE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approval for the original ANDA of dalfampridine from Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

ORIG AP for DALFAMPRIDINE (DALFAMPRIDINE)